--- title: "Marcus & Millichap (MMI) After Its Profit Return And Dividend Why Valuation Still Looks In Focus" type: "News" locale: "en" url: "https://longbridge.com/en/news/296000602.md" description: "Marcus & Millichap (MMI) returned to profit in Q2 2026, completed a multi-year share buyback, and declared a new dividend. Despite recent positive momentum with YTD returns of 17.01%, the stock is considered overvalued at $31.58 against a fair value estimate of $28.00. While improving lending environments boost revenue prospects, risks include potential transaction weakness and margin compression." datetime: "2026-08-15T11:43:58.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296000602.md) - [en](https://longbridge.com/en/news/296000602.md) - [zh-HK](https://longbridge.com/zh-HK/news/296000602.md) generator: "portal-rs" --- # Marcus & Millichap (MMI) After Its Profit Return And Dividend Why Valuation Still Looks In Focus Marcus & Millichap (MMI) has drawn investor attention after reporting second quarter 2026 results that shifted from a loss to a profit, alongside a completed multi year share buyback and a fresh dividend declaration. See our latest analysis for Marcus & Millichap. At a share price of $31.58, Marcus & Millichap has posted a 90 day share price return of 12.07% and a year to date share price return of 17.01%. The 1 year total shareholder return of 4.40% and 5 year total shareholder return decline of 11.50% suggest that momentum has improved more recently compared with the longer term. If this mix of shorter term progress and longer term caution has you comparing opportunities, it could be a good time to scan the market using 20 top founder-led companies After Marcus & Millichap’s return to profit, completed buyback and new dividend, investors may weigh paying up at today’s price against waiting for a pullback. So how does the current valuation compare? ## Most Popular Narrative: 12.8% Overvalued At $31.58, Marcus & Millichap sits above the most followed fair value estimate of $28.00, so the gap between price and narrative is already in focus. > *The company is benefiting from renewed institutional investor activity and an improving lending environment, which is fueling larger transaction volumes and a stronger capital markets pipeline, both factors that are likely to boost future revenue and earnings growth.* *Read the complete narrative.* Want to see why this fair value still sits below today’s price? The narrative leans heavily on rising revenues, fatter margins and a richer future earnings multiple. **Result: Fair Value of $28.00 (OVERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, the Marcus & Millichap narrative can break if transaction driven revenue weakens, or if fee compression and client pushback on commissions hit margins harder than expected. Find out about the key risks to this Marcus & Millichap narrative. ## Next Steps If the mix of fresh profits, completed buybacks and a new Marcus & Millichap dividend leaves you on the fence, now is a good time to test the numbers and sentiment yourself by weighing both the potential upsides and the issues investors are watching through 2 key rewards and 1 important warning sign ## Looking for more investment ideas beyond Marcus & Millichap? If you are weighing Marcus & Millichap against other opportunities, now can be a time to widen your watchlist and see what else stands out. - Spot potential bargains early by scanning companies that look attractively priced on fundamentals using the 50 high quality undervalued stocks. - Boost your focus on income by checking out stocks that meet high yield and resilience criteria through the 10 dividend fortresses. - Strengthen your downside protection by filtering for companies with robust financial footing using the 83 resilient stocks with low risk scores. *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.* ### **New:** Manage All Your Stock Portfolios in One Place We've created the **ultimate portfolio companion** for stock investors, **and it's free.** • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Try a Demo Portfolio for Free ### Related Stocks - [MMI.US](https://longbridge.com/en/quote/MMI.US.md) ## Related News & Research - [Marcus & Millichap brokers sale of three Illinois Freddy’s net-lease properties for $5.76 million](https://longbridge.com/en/news/297566415.md) - [Marcus & Millichap brokers sale of 110,344-sq-ft industrial property in Effingham, Illinois](https://longbridge.com/en/news/297703550.md) - [Marcus & Millichap brokers sale of 950-unit Springtown, Texas self-storage portfolio](https://longbridge.com/en/news/297373888.md) - [Marcus & Millichap brokers sale of Conrad Pearson Clinic medical office building for $24.5 million](https://longbridge.com/en/news/297066951.md) - [Marcus & Millichap brokers sale of Chicago Lincoln Park multifamily property for $20.4 million](https://longbridge.com/en/news/296527314.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**